Isolated hypomagnesaemia presenting as focal seizures in diabetes mellitus
Hypomagnesaemia is a well known association of diabetes mellitus; it is often asymptomatic but may manifest as tremor, tetany, delirium, hallucinations, or, when severe, generalised seizures. In such instances it is usually associated with hypocalcaemia. We report on a diabetic patient with severe hypomagnesaemia but normocalcaemia who developed focal seizures that proved refractory to conventional anticonvulsant treatment but were abolished when the serum magnesium concentration was corrected.
Case report A 69 year old housewife presented with a three day history of headache and confusion. For 12 years she had suffered from non-insulin dependent diabetes, rheumatoid arthritis, and migraine. There was no history of epileptic fits or transient ischaemic attacks. She was taking glibenclamide, prednisolone, and frusemide.
On examination she was obtunded with left homonymous hemianopia and left sensory inattention. On the day of admission she suffered at least 12 episodes of involuntary head and eye turning (mainly to the left), with associated periods of absence lasting up to two minutes; her husband confirmed that these attacks had started only two days earlier. Investigations showed blood glucose concentration 14 7 mmol/l (265 mg/100 ml), haemoglobin Alc 1833% (normal range 5-8%), corrected plasma calcium 2 25 mmol/l (9-0 mg/100 ml; normal range 2 20-2-62 mmol/l (8-8-10-5 mg/100 ml)), plasma phosphate 1 03 mmol/l (3-1 mg/100 ml), and plasma potassium 3-8 mmol(mEq)/l. Plasma urea, sodium, and bicarbonate concentrations were normal, as were cardiac enzyme activities. A computed tomogram of the brain was normal, an electroencephalogram showed epileptic activity in the right hemisphere, and her cerebrospinal fluid was normal except for a slightly increased protein concentration (0-7 g/l).
A parieto-occipital infarct with associated focal fits was diagnosed initially. Despite control of her blood glucose concentration with an insulin infusion and phenytoin (a loading dose of 1 g in the first 24 hours followed by 300 mg daily) she continued to fit every four hours. Forty eight hours after admission her serum magnesium concentration was 0-29 mmol/l (0 7 mg/100 ml), and this was verified on four successive occasions within 24 hours (normal range 0-7-1-0 mmol/l (1-7-24 mg/100 ml)). Magnesium sulphate 3 g was infused over four hours, and within 12 hours her fits had become less frequent. They had stopped altogether by 30 hours, after a further infusion of 2 g ( figure) . Over the next four days her Days after admission Aversive seizures and magnesium sulphate infusions in relation to serum magnesium and plasma glucose concentrations. Conversion: SI to traditional units-Serum magnesium: 1 mmol/1-2-4 mg/100 ml. Plasma glucose: 1 mmol/l1v18 mg/I00 ml. neurological signs resolved completely, by which time the serum magnesium concentrationhad become stableat063 mmol/l (1-5 mg/100ml). Neitherarepeat computed tomogram nor a nuclear magnetic resonance scan of the brain showed any evidence of cerebral infarction. She had no further fits after discharge, and anticonvulsants were stopped after six months.
Comment
Mild hypomagnesaemia is common in diabetes mellitus. It may occur in a quarter ofdiabetic outpatients,2 and plasma magnesium concentration varies inversely with blood glucose concentration in these patients.3 During the treatment of diabetic ketoacidosis the plasma magnesium concentration may fall severely such that magnesium supplements are required.4 Although our patient was not ketotic, her diabetes was undoubtedly poorly controlled. In addition, she was taking frusemide, and diuretics are known to induce hypomagnesaemia.5 This combination may have accounted for the severity of her hypomagnesaemia.
The neurological consequences of hypomagnesaemia range from muscular twitching to generalised seizures. Our patient presented with signs of a right sided parieto-occipital lesion and focal seizures refractory to conventional anticonvulsant treatment. These resolved completely on correction of her profound hypomagnesaemia. To our knowledge such focal seizures and neurological deficits have not been reported previously in association with hypomagnesaemia.
We suggest that the possibility of hypomagnesaemiia be borne in mind when a diabetic presents with unexplained focal neurological signs. It may occur in the absence of other electrolyte disturbances and ketosis. Prompt replacement of this essential ion will lead to rapid resolution of the neurological deficit.
We thank Dr L C A Watson for permission to report on his patient. 
Mercury hazards arising from the repair of sphygmomanometers
The symptoms of inorganic mercury poisoning are well described 12; poisoning is known to have occurred in manufacturers of scientific instruments but not in people repairing sphygmomanometers.3 Early neuropsychiatric symptoms in one repairer led to the investigation of six sphygmomanometer workshops in Scotland.
Case reports A 37 year old man worked for up to 60 hours a week for three years in a small, poorly ventilated room (volume roughly 140 m3) whose winter temperature sometimes exceeded 27C. He spent 5-10% of his time repairing sphygmomanometers containing mercury. He took refreshment and smoked cigarettes at his work. For a year he complained of worsening neuropsychiatric symptoms including tremor, forgetfulness, and irritability. His symptoms were initially attributed to overwork, until a 24 hour urine collection showed mercury concentrations of 200 nmol/mmol creatinine (400 [tg/g). The upper 95th percentile for unexposed workers is less than 2 nmol/mmol creatinine (4 [tg/g).
Nerve conduction velocity and results of urine analysis and haematological, biochemical, ophthalmological examinations were normal. His symptoms improved as his urinary mercury concentration fell to more normal values, but he still complained of forgetfulness.
All subsequent urinary mercury concentrations in this patient and 20 other workers were determined using spot samples of early morning urine.
The index patient's 17 year old son developed a desquamating rash on his hands and forearms. His urinary mercury concentration was 91 nmollmmol creatinine (182 pg/g). Acrodynia was diagnosed. Three workers working in the same premises as the index case were found to have urinary mercury concentrations of 12-70 nmol/mmol creatinine (24-140 ig/g). None had symptoms.
A visit to the premises showed contamination of work surfaces; when the floor and bench coverings were lifted many small globules of mercury were evident. Decontamination was tried, but six months afterwards an environmental survey carried out by an occupational hygienist (Wolfson Institute, Ninewells Hospital, Dundee) with a Baccarah mercury sniffer MV2 showed levels of mercury in air in the workshop to be six to 10 times the recommended limit (0 05 mg/ni3). The highest levels were found near a chair in which the index patient sat.
Sixteen employees in five other sphygmomanometer workshops throughout Scotland produced specimens of urine with mercury concentrations of 2-139 nmol/mmol creatinine (4-278 Rg/g). The employee with the highest concentration had symptoms, but these were more probably attributable to alcohol. None of the others had symptoms.
Environmental monitoring in one of the workshops (four employees) by an
